Acute and mid-term results of phosphorylcholine-coated stents in primary coronary stenting for acute myocardial infarction

scientific article (publication date: June 2001)

Acute and mid-term results of phosphorylcholine-coated stents in primary coronary stenting for acute myocardial infarction is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/CCD.1145
P698PubMed publication ID11387601

P2093author name stringF Prati
M Galli
G Ferrari
S Mameli
A Pagano
L Sommariva
A Politi
E Butti
R Bonatti
S Zerboni
P2860cites workAssessment of risk area during coronary occlusion and infarct size after reperfusion with myocardial contrast echocardiography using left and right atrial injections of contrastQ30467112
Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study GroupQ33884453
A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study GroupQ34360479
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stentsQ34374902
Coronary Palmaz-Schatz stent implantation in acute myocardial infarctionQ36829429
Fibrin-film stenting in a porcine coronary injury model: efficacy and safety compared with uncoated stentsQ38552029
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative reviewQ38554587
Emergency coronary angioplasty for acute myocardial infarction: predictors of early occlusion of the infarct-related artery after balloon inflation.Q41084255
Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial InvestigatorsQ43645713
Timing and mechanism of in-hospital and late death after primary coronary angioplasty during acute myocardial infarctionQ44059042
Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial InvestigatoQ46169319
A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. Myocardial Infarction Triage and Intervention Investigators.Q52889936
Polymeric stenting in the porcine coronary artery model: differential outcome of exogenous fibrin sleeves versus polyurethane-coated stents.Q53987059
A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarctionQ70562086
Stent implantation in acute myocardial infarctionQ71076681
Intracoronary stenting in acute myocardial infarctionQ71988049
Coronary stenting for acute myocardial infarctionQ72340480
Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trialsQ72369172
Failed direct coronary angioplasty for acute myocardial infarction: in-hospital outcome and predictors of deathQ72887986
A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) trialQ74530433
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectmyocardial infarctionQ12152
acute myocardial infarctionQ18558122
P304page(s)182-7
P577publication date2001-06-01
P1433published inCatheterization and Cardiovascular InterventionsQ2352240
P1476titleAcute and mid-term results of phosphorylcholine-coated stents in primary coronary stenting for acute myocardial infarction
P478volume53

Reverse relations

cites work (P2860)
Q41959642Covalent surface modification of a titanium alloy with a phosphorylcholine-containing copolymer for reduced thrombogenicity in cardiovascular devices.
Q51010874Effects of photo-induced graft polymerization of 2-methacryloyloxyethyl phosphorylcholine on physical properties of cross-linked polyethylene in artificial hip joints.
Q38024604Haemocompatibility of titanium and its alloys
Q36412659Is there an alternative to systemic anticoagulation, as related to interventional biomedical devices?
Q35227345Simple surface modification of a titanium alloy with silanated zwitterionic phosphorylcholine or sulfobetaine modifiers to reduce thrombogenicity
Q35088541State of the art in coronary intervention
Q46496368Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model
Q37026938Surface modification of a biodegradable magnesium alloy with phosphorylcholine (PC) and sulfobetaine (SB) functional macromolecules for reduced thrombogenicity and acute corrosion resistance
Q41852891Surface modification of a titanium alloy with a phospholipid polymer prepared by a plasma-induced grafting technique to improve surface thromboresistance.
Q36282715The future of drug eluting stents

Search more.